Donate to Advance Research for Ovarian and Gynecologic Cancers

OCRA is the global leader in research funding and a trailblazer in the race to find a cure for ovarian and related gynecologic cancers. Your donation supports promising cancer research and patient support programs.

Your support is funding cures

OCRA is leading the charge against ovarian and related gynecologic cancers, toward a world where better prevention means fewer diagnoses, where everyone touched by the disease can find compassionate, comprehensive support, and where every single patient can be successfully treated. We need your help as we pursue our commitment to inspiring hope, advancing science, and moving the world closer to a cure.

Make a monthly donation

How to Donate to Cancer Research

We offer several convenient ways for you to support the fight against ovarian and gynecologic cancers. Whether you prefer to give online, by mail, or through a financial gift, every contribution makes a meaningful impact. Choose the option that works best for you below.

Donate Online

Our secure online form is the quickest and easiest way to make an immediate impact. You can make a one-time gift or become a monthly donor to provide steady support for our researchers and patients throughout the year.

Donate by mail or phone

To donate by mail, please send checks to:

Ovarian Cancer Research Alliance
PO Box 32141
New York, NY 10087-2141

Tax ID #13-3806788

To donate by credit card over the phone, please call 212-268-1002.

Donate to Cancer Research

Reasons to Donate to Cancer Research

Your donation fuels the fight against gynecologic cancers, from the laboratory to the halls of Congress to the halls of Congress, and by the sides of patients and their loved ones from the moment of diagnosis, through treatment, and beyond. By donating to OCRA, you:

Lead the Scientific Fight

Fund more ovarian cancer research than any other public charity in the world. We have invested $137 million to date in the most innovative science, fueling breakthroughs and attracting the brightest minds to the field.

Provide Free Support at No Cost

Help us support over 95,000 individuals annually with free programs like our Woman to Woman peer mentoring, a patient support line staffed by social workers, and 1:1 professional counseling. We ensure no one faces this disease alone.

Drive Policy Change

Serve as the only dedicated voice on Capitol Hill for ovarian and all gynecologic cancers. Our advocacy has helped secure over $3.8 billion in federal research and education funding, directly impacting policy and access to care.

Connect Patients to New Treatments

Give patients access to potentially life-saving therapies through our Clinical Trial Navigator. We provide personalized support to help patients find clinical trials tailored to their specific diagnosis and treatment history.

Donate with Absolute Confidence

Trust in our proven financial stewardship. For each dollar we spend, 81 cents goes to funding critical research and innovative programs. We have also earned the highest ratings from Charity Navigator, BBB Wise Giving Alliance, and GuideStar.

Support The Rivkin Pilot Grant

The Rivkin Pilot Grant paves the way for innovative breakthroughs in all areas of ovarian cancer research. OCRA is proud to continue the Rivkin Center’s extraordinary legacy of hope, determination, and relentless pursuit of a cure.

Make a Donation

Frequently Asked Questions

: Yes. When you give to Ovarian Cancer Research Alliance, your donation is tax-deductible thanks to our 501(c)(3) nonprofit status.
: Your donation supports the most promising research to improve outcomes, and our vital support and education programs. All of OCRA’s programs are free, which ensures anyone facing any gynecologic cancer has access to vital support and education. Through these services, OCRA provides tools to help individuals better understand their disease and work with their doctors to find the best treatments.
: Research is essential to creating better outcomes for those with ovarian and other gynecologic cancers. It directly supports the development of new screening methods for earlier detection and more effective, personalized treatments that can lead to better outcomes for patients.